Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours

Background: Denosumab offers an alternative, or additional, treatment for the prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumours. Objectives: The aim of this review was to assess the clinical effectiveness and cost-effectiveness of denosumab, within its...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: J Ford, E Cummins, P Sharma, A Elders, F Stewart, R Johnston, P Royle, R Jones, C Mulatero, R Todd, G Mowatt
Formato: Artigo
Idioma:Inglês
Publicado em: NIHR Journals Library 2013-07-01
Colecção:Health Technology Assessment
Assuntos:
best supportive care
bone metastases
cost-effectiveness
denusomab
solid tumours
systematic review
zoledronic acid
Acesso em linha:https://doi.org/10.3310/hta17290
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados